Effects of intramyocardial injection of platelet-rich plasma on the healing process after myocardial infarction

Coronary Artery Disease

Volumn 19, Issue 5, 2008, Pages 363-370

  Li, Xiao Hong ^a   Zhou, Xin ^a,b   Zeng, Shan ^a   Ye, Fan ^a   Yun, Ji Li ^a   Huang, Ti Gang ^b   Li, He ^a   Li, Yu Ming ^a  

^a MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Healing; Myocardial infarction; Paracrine; Platelet; Ventricular remodeling

Indexed keywords

THROMBIN; VASCULOTROPIN; ANGIOGENIC FACTOR; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; HEART INFARCTION; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; MALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA; WOUND HEALING; ANIMAL; DRUG EFFECT; HEART; HEART VENTRICLE FUNCTION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; THROMBOCYTE ACTIVATION; WISTAR RAT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; HEART; MALE; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; PLATELET-DERIVED GROWTH FACTOR; PLATELET-RICH PLASMA; RATS; RATS, WISTAR; THROMBIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR FUNCTION; VENTRICULAR REMODELING; WOUND HEALING;

EID: 58149105498     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3282fc6165     Document Type: Article

References (24)

1. Weir RA, McMurray JJ, Velazquez EJ. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. Am J Cardiol 2006; 97:13F-25F.
2. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53:31-47.
3. Rajkumar VS, Shiwen X, Bostrom M, Leoni P, Muddle J, Ivarsson M, et al. Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am J Pathol 2006; 169:2254-2265.
4. Rendu F, Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets 2001; 12:261-273.
5. Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 2005; 84:434-439.
6. Ma L, Elliott SN, Cirino G, Buret A, Ignarro LJ, Wallace JL. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci U S A 2001; 98:6470-6475.
7. Clappers N, Brouwer MA, Verheugt FW. Antiplatelet treatment for coronary heart disease. Heart 2007; 93:258-265.
8. Cenni E, Ciapetti G, Pagani S, Perut F, Giunti A, Baldini N. Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts. J Periodontol 2005; 76:323-328.
9. Zhou X, Li YM, Ji WJ, Jiang TM, Sun XN, Zhu Y, et al. Phenytoin can accelerate the healing process after experimental myocardial infarction? Int J Cardiol 2006; 107:21-29.
10. Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987; 75: 299-306.
11. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005; 115:2108- 2118.
12. Rich L, Whittaker P. Collagen and picrosirius red staining: a polarized light assessment of fibrillar hue and spatial distribution. Braz J Morphol Sci 2005; 22:1-12.
13. Dedkov EI, Christensen LP, Weiss RM, Tomanek RJ. Reduction of heart rate by chronic beta1-adrenoceptor blockade promotes growth of arterioles and preserves coronary perfusion reserve in postinfarcted heart. Am J Physiol Heart Circ Physiol 2005; 288:H2684-H2693.
14. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol 2004; 25:489-495.
15. Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML, et al. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol 2006; 48:2315-2323.
16. Tozum TF, Demiralp B. Platelet-rich plasma: a promising innovation in dentistry. J Can Dent Assoc 2003; 69:664.
17. Whittaker P. Collagen organization in wound healing after myocardial injury. Basic Res Cardiol 1998; 93 (Suppl 3):23-25.
18. Cittadini A, Stromer H, Katz SE, Clark R, Moses AC, Morgan JP, et al. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation 1996; 93:800-809.
19. Tan Y, Shao H, Eton D, Yang Z, Alonso-Diaz L, Zhang H, et al. Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor. Cardiovasc Res 2007; 73:823-832.
20. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4 + hemangiocytes. Nat Med 2006; 12:557-567.
21. Elmadbouh I, Haider H, Jiang S, Idris NM, Lu G, Ashraf M. Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol 2007; 42:792-803.
22. Eligini S, Barbieri SS, Arenaz I, Tremoli E, Colli S. Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: role of transforming growth factor-beta1. Cardiovasc Res 2007; 74:270-278.
23. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005; 11:367-368.
24. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195-1201.